Similar Articles
971 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
972 Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience
973 Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria
974 Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
975 Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma
976 Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
977 miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
978 Application of cystoscope in surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
979 Hepatocellular carcinoma after locoregional therapy: Magnetic resonance imaging findings in falsely negative exams
980 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA